Reverse-Engineering of Exclusive Enteral Nutrition (RE-EEN) in Crohn's Disease: A Multi-Center Trial - Trial NCT06216899
Access comprehensive clinical trial information for NCT06216899 through Pure Global AI's free database. This phase not specified trial is sponsored by Seattle Children's Hospital and is currently Not yet recruiting. The study focuses on Crohn Disease. Target enrollment is 60 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Seattle Children's Hospital
Timeline & Enrollment
N/A
Mar 01, 2024
Jan 10, 2027
Primary Outcome
Tolerance- Ability to remain on prescribed nutritional therapy
Summary
This study will compare the tolerability and efficacy of conventional formula Exclusive
 Enteral Nutrition (EEN) and whole-food blended smoothie EEN by enrolling a total of 60
 participants with newly diagnosed pediatric Crohn's disease (CD).
 
 Participants will be provided either commercial formula or guided on the preparation of the
 home-blended smoothie. These participants will be given a specific recipe, blender, and be
 provided the food components to the smoothie. The study will total 8 weeks and will assess
 tolerance, clinical outcomes, stool microbiome, and quality of life.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06216899
Non-Device Trial